Dexmedetomidine Hcl 100 Mcg/mL Inj
LB.02.01/Vll/011/KEP011/2022
Phase 3 small_molecule completed
Quick answer
Dexmedetomidine Hcl 100 Mcg/mL Inj for Congenital Heart Disease in Children is a Phase 3 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Congenital Heart Disease in Children
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed